References
- Alosh, M., Huque, M. F. (2009). A flexible strategy for testing subgroups and overall population. Statistics in Medicine 28:3–23. doi:10.1002/sim.v28:1.
- Alosh, M., Huque, M. F. (2010). A consistency-adjusted alpha-adaptive strategy for sequential testing. Statistics in Medicine 29:1559–1571.
- Freidlin, B. (2005). Adaptive signature design: An adaptive clinical trial design for generating 1519 and prospectively testing A gene expression signature for sensitive patients. Clinical Cancer 1520 Research 11:7872–7878. doi:10.1158/1078-0432.CCR-05-0605.
- Freidlin, B., Jiang, W., Simon, R. (2010). The cross-validated adaptive signature design. Clinical Cancer 1522 Research 16:691–698. doi:10.1158/1078-0432.CCR-09-1357.
- Hall, P., Wilson, S. (1991). Two guidelines for bootstrap hypothesis testing. Biometrics 47(2):757–762. doi:10.2307/2532163.
- Jiang, W., Freidlin, B., Simon, R. (2007). Biomarker-adaptive threshold design: A procedure for evaluating treatment with possible biomarker-defined subset effect. Journal of the National Cancer Institute 99(13):1036–1043. doi:10.1093/jnci/djm022.
- Lyles, R., Lin, J. (2010). Sensitivity analysis for misclassification in logistic regression via likelihood methods and predictive value weighting. Statistics in Medicine 29(22):2297–2309.
- Song, Y., Chi, G. Y. (2007). A method for testing a prespecified subgroup in clinical trials. Statistics in Medicine 26:3535–3549.